Heidi A. Erickson, Ph.D. - Publications

Affiliations: 
2004 University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Molecular Biology, Immunology, Oncology

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Tyner JW, Deininger MW, Loriaux MM, Chang BH, Gotlib JR, Willis SG, Erickson H, Kovacsovics T, O'Hare T, Heinrich MC, Druker BJ. RNAi screen for rapid therapeutic target identification in leukemia patients. Proceedings of the National Academy of Sciences of the United States of America. 106: 8695-700. PMID 19433805 DOI: 10.1073/Pnas.0903233106  0.374
2008 Tyner JW, Walters DK, Willis SG, Luttropp M, Oost J, Loriaux M, Erickson H, Corbin AS, O'Hare T, Heinrich MC, Deininger MW, Druker BJ. RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia. Blood. 111: 2238-45. PMID 18025156 DOI: 10.1182/Blood-2007-06-097253  0.339
2006 Erickson HA, Jund MD, Pennell CA. Cytotoxicity of human RNase-based immunotoxins requires cytosolic access and resistance to ribonuclease inhibition. Protein Engineering, Design & Selection : Peds. 19: 37-45. PMID 16243897 DOI: 10.1093/Protein/Gzi073  0.492
2002 Pennell CA, Erickson HA. Designing immunotoxins for cancer therapy. Immunologic Research. 25: 177-91. PMID 11999171 DOI: 10.1385/Ir:25:2:177  0.479
2001 Erickson HA, Reinhardt RL, Hermanson JB, Panoskaltsis-Mortari A, Pennell CA. Visualization of immunotoxin-mediated tumor cell death in vivo. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 7: 890s-894s. PMID 11300488  0.472
Show low-probability matches.